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Background: Tobacco is the only consumer product known to kill half of its users, and is a significant cause of
death and disability to exposed nonsmokers. This presents a unique conundrum for modern democracies, which
emphasize personal liberty, yet are obligated to protect citizens.
In Israel, the death toll in 2014 from smoking is expected to reach 8000 deaths; nearly a fifth of the population
smokes, and over two-thirds of the population are exposed to tobacco smoke.
Aim: This paper provides an overview of tobacco policy in Israel since the inception of the State, presents the
development of the National Tobacco Control Plan, and recommends future actions.
Methods: Sources for this article included the Knesset (Israeli Parliament) and Ministry of Health websites, Health
Minister Reports to the Knesset on Smoking, and the scientific literature.
Results: Israel has an impressive record on tobacco control policy, beginning with taxation in 1952, landmark
smoke-free air and marketing legislation in the early 1980’s, tax increases and expansions of smoke-free air and
marketing legislation in the ensuing years, and the addition of subsidized smoking cessation technologies in
2010. Until 2011, actions were taken by various organizations without formal coordination; since the passage of
the National Tobacco Control Plan in 2011, the Ministry of Health has held responsibility for coordinating tobacco
control, with an action plan.
The plan has been partially implemented. Smoke-free air laws were expanded, but enforcement is poor. Passage of
critical marketing and advertising restrictions is stalled. Requested funds for tobacco control did not materialize.
Recommendations: In order to prevent hundreds of thousands of preventable premature deaths in the coming
decades, Israel should considerably strengthen tobacco control policies to include: guaranteed funding for tobacco
control; strong curbs on advertising, promotion and sponsorship of tobacco and smoking products; public education;
law enforcement; protection of children from exposure to tobacco; regulation of electronic cigarettes and other
alternative harm-reducing products; tobacco control research; and systematic monitoring of, and periodic updates to,
the National Tobacco Control Plan. Israel should also begin discussions of Endgame scenarios, and consider abolition
of tobacco, as it continues its progress towards making smoking history.
Keywords: Tobacco control, Tobacco policy, Health policy, MPOWER, FCTC, Legislation, Israel, Smoking, Secondhand
smoke, Tobacco smoke exposureBackground
Tobacco is the only consumer product known to kill half
of its users, and is a significant cause of death and dis-
ability to nonsmokers exposed to tobacco smoke [1].
This presents a unique conundrum for modern democ-
racies. On the one hand, tobacco consumption is initially
a personal decision, the risks are well-known, and* Correspondence: rosenl@post.tau.ac.il
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stated.democracies are loath to regulate personal behavior even
when it is known to damage the health of the individual.
On the other hand, harm to society through premature
death and disability of users and those exposed is enor-
mous. Complicating the story are the enormous power
of the transnational tobacco companies, the strength of
the tobacco lobby in many countries, and the depend-
ence of many governments on direct and indirect reve-
nues from tobacco [2].
Israel, a modern democracy of just over eight million
citizens [3], has witnessed a decline of more than 50% inCentral. This is an Open Access article distributed under the terms of the Creative
mmons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
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40 years [4]. Just under a fifth of Israeli adults (18.7%,
2013) currently smoke [4]; this is slightly higher than
current levels in the U.S. (17.8%, 2013) [5], and Canada
(17.3%, 2011) [6]. The change observed in Israel parallels
that seen in other developed nations, as it places Israel
squarely in the third to fourth phase of the epidemio-
logic curve of tobacco use, in which both male and fe-
male smoking levels are on the decline [7,8]. This
decrease has occurred despite millions of New Israeli
Shekels (NIS) of annual investment in tobacco advertis-
ing, sponsorship, and promotion by the tobacco indus-
try, particularly by the transnational tobacco companies
[4]. Though progress has been considerable, the harm
of smoking in Israel continues: the death toll from to-
bacco use and exposure was estimated to be 10,000
Israelis in 2003, comprising 22% of mortality [9], and is
expected to be about 8000 in 2014, more than the
combined mortality from vehicle accidents, suicides,
murders, obesity, lack of physical activity, and motor
vehicle emissions combined [10]. This suggests that
over the coming decades, several hundred thousand
Israelis will die prematurely due to active smoking or
exposure to tobacco smoke.
The aim of this paper is to explore Israel’s governmental
tobacco policy, in the context of the continuing decline in
smoking rates in the population. We explore two inter-
related areas of action: one, the passage of piecemeal
tobacco control legislation, and two, the complex,
multi-faceted process of building, passing, and imple-
menting an integrated National Tobacco Control Plan.
Methods
We used the following sources of information: the
Knesset (Israeli Parliament) website [11], which con-
tains a complete record of all attempts (successful and
unsuccessful) to pass tobacco regulation since 1999;
Minister of Health (MoH) Reports to the Knesset,
which since 2001 have provided an annual update on
smoking prevalence and tobacco control actions; MoH
website [12], which includes a record of all Ministry-
issued directives since 1980; and articles published in
the professional literature. We also conferred with indi-
viduals active in tobacco control in Israel, including
professionals in the MoH.
We first present an overview of tobacco use and ex-
posure in Israel during the years 1970–2013, and then
identify players in tobacco control in Israel. We next
focus on highlights in Israeli tobacco policy, utilizing the
concepts of the World Health Organization’s (WHO)
MPOWER structure [13]. MPOWER was a plan devel-
oped by the WHO to aid countries in reducing the de-
mand for tobacco. We then describe the growth,
development, and adoption of Israel’s National TobaccoControl Plan (NTCP). We conclude with recommenda-
tions for further action.
Results
Overview of tobacco use and exposure to tobacco smoke
in the Israeli population
Published information on tobacco use in Israel among
Jews dates back to 1972 [14]. At that time, 43% of Jewish
men and 30% of Jewish women were smokers. Data on
smoking among Arabs is available from 1996; at the
time, smoking prevalence among Arab males was about
50% and among Arab females was about 12%. The most
recent data, published in May, 2014, show that smoking
among Israeli adults declined to 18.7% in 2013, and that
declines were apparent in all four population sectors
(Jewish men: 21.4%, Jewish women: 14.6%, Arab men:
39.2%, Arab women: 5.9%) [4] (See Figure 1).
Unlike information on active smoking, information on
passive smoking has been collected only sporadically,
and trends are unavailable. A study conducted in 2010
and based on a representative sample of Israeli adults
found that roughly 70% of Israelis reported exposure at
least weekly to tobacco smoke [15]. Results from the
first Israeli Human Biomonitoring Study, conducted in
2011, showed that 62.2% of nonsmoking Israelis had
urinary cotinine levels indicative of tobacco smoke ex-
posure [16]. Data from 2013 showed that about 40% of
nonsmoking Israeli adults reported exposure to second-
hand smoke [4]. (P.11). In 2003–2004, nearly 86% of
school children (7th-12th graders) reported regular ex-
posure to tobacco smoke, with 40% of them exposed on
a regular basis at school [17]. Parentally-reported expos-
ure of infants between 2009–2012 showed that 31.5% of
infants aged 0–2 were exposed to tobacco smoke at least
occasionally. (Jewish infants: 24.8%, Arab infants: 52.0%)
[18] (p.176-178).
Players in tobacco control in Israel
There are a number of players involved in tobacco con-
trol in Israel. Many of these are within the government:
in addition to the MoH (including: the Department of
Health Promotion and Education, which is located
within the Public Health Services Branch, the Legal De-
partment, the District Health Offices, and the Depart-
ment of Maternal and Child Health), the following
Ministries are involved: the Ministry of Finance, the
Ministry of Education, the Ministry of Industry and
Commerce (now, the Ministry of Economy), the Minis-
try of the Interior, as well as the municipal authorities,
and the police. Public (non-profit) and voluntary organi-
zations are also active. The Israel Cancer Association
was the earliest leader in tobacco control, and has con-
tinued to spearhead activities for decades, running im-
portant media campaigns, initiating policy and legislative
Figure 1 Major tobacco policy landmarks, tobacco taxation, and population smoking prevalence and exposure 1948–2013.
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schools and teen smoking prevention, running lectures
and seminars, and collaborating with other organizations
[19]. The four Israeli HMOs, the Israel Association for
Smoking Prevention, and the Healthy Cities Association
have been active for many years. More recently, the
Medical Association for Prevention of Smoking wasestablished, as were several grass roots organizations,
such as the Clean Air Organization and Haviv.
Highlights of tobacco policy
In this section, we present, in chronological order, the
highlights of tobacco policy and regulation from the in-
ception of the State of Israel in 1948 through the
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tional Tobacco Control Plan in 2011, though the major
tobacco control legislation was under the authority of
the MoH, comprehensive tobacco-related policy was not
officially under the jurisdiction of any single body or
Ministry. Rather, it was promoted by various individuals
and entities with varying agendas, albeit usually in col-
laboration with MoH personnel.
Tables 1, 2 and 3 present chronological details of pol-
icy efforts in the areas of 1- taxation, 2 - smoke-free
public areas, and 3 – marketing, sales and promotion of
tobacco products.
For each major item, we identify the relevant section of
the WHO’s MPOWER framework [13], and summarize
continued actions in each area which took place subse-
quent to the initial actions. In Figure 1, the major land-
marks are juxtaposed graphically against population
smoking prevalence and exposure.
1952-present: Taxation (MPOWER: raise taxes on tobacco)
Initiated in 1952, taxation of tobacco products is the
oldest public health tool in the Israeli tobacco control
scheme. It did not start as a public health tool, but ra-
ther as a fiscal one, and thus was placed under the sole
authority of the Minister of Finance. The money raised
by the tobacco retail tax was not designated for any par-
ticular use, and went into the general budgetary pool.Table 1 Changes to sales tax on cigarettes in Israel 1995-201




1952b ↑ Consumer price 53%











June 2005 ↑ 62% 49.49
May 2009 ↑ 63% 62.5
June 2009 - wholesale price
(consumer price + VAT)
225.7% 203.5
July 2009 - 231.7% 194
July 2010 ↑ 260.6% 214.5
July 2012 ↑ 278.6% 274.5
May 2013 ↑ 270% 391.5
aBase upon Israel’s State Revenue Administration’s annual report for the years 2011
bBetween the years 1952–1995 tobacco taxing was mainly driven by budgetary nee
↑Represents an increase in taxation.Due to the combination of pressure from the MoH to
increase tobacco taxation for health reasons, and the
pressure on the Treasury to balance a tight budget, the
amount of all taxes imposed on cigarettes in Israel rose
steadily, with a significant increase of over 10% between
the years 2002–2013, to 80.13% today. This is just short
of the EU average of 80.77% [4]. (p.81) Details can be
found in Table 1.
1982 – present: Smoke-free laws (MPOWER: protect
people from tobacco smoke)
Early legislation for restricting smoking in public places
was initiated by the MoH in 1982 [20]. At the time, such
actions were uncommon in other countries. The meas-
ure, applicable only to interior areas of hospitals, stipu-
lated that smoking would be forbidden on hospital
wards, allowed only in designated rooms which were not
used for the treatment of patients, and that no-smoking
signs should be centrally hung around wards, treating
rooms and corridors.
This was followed by the landmark 1983 Restriction
on Smoking in Public Places Act [21], which prohibited
smoking in buses, taxis, pharmacies, libraries, educa-
tional and medical facilities (excluding designated smok-
ing areas), elevators, movie theatres and other public
halls. In a series of extensions to that law, smoking was
prohibited in additional indoor places including public3a
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ds, and fluctuated several times, until coming back to 53%.
Table 2 Legislation regarding Restriction of smoking in public places 1983–2014








in public places act
1983 Ban on smoking in cinemas and show theatersa, medical
facilitiesa, communal areas in pharmacies, librariesa,
educational facilitiesa, elevators, busses, taxis
Restriction on smoking in public
places regulations (Sign placement)
1984 “No smoking” sign required
1988 Added banned venues - trainsa, communal areas in
supermarkets, dinersa, coffee-shopsa, restaurantsa, gyms
and kindergartens.
Restriction on smoking in public
places Regulations (Ushers)
1988 Property owner/holder allowed to appoint ushers to
impose the “no-smoking” ban.
1990 Added banned venues - communal areas in banks and
post-offices
1994 Added banned venues – workplacesa
2001 Allowed “smoking area” changed into allowed “separate
smoking room”, smoking entirely prohibited in hospital
buildings, added banned venues - banquet hallsa, mallsa
Public Health Regulations
(Prohibition of Smoking in hospitals)
2004 Hospital directors must appoint ushers, charged with
upholding the smoking ban
2005 Appointment of “no smoking” ushers in hospitals.
Prevention of smoking in
public places and exposure
to second-hand smoke Act
(Name of act changed)
2007 Added banned venue: barsa and pubsa, duty of supervision
and criminal responsibility imposed on property owner/
occupant, municipal authorities required to appoint
non-smoking supervisors, smoking prohibitions extended
to apply to security forces.
Criminal Procedure Order
(fine offenses - preventing
smoking in public places)
2007 Violation of the prohibition of smoking in public places is
fineable without trail.
2012 Added banned venues – entrances to medical facilities,
partial outdoors of any food or beverage serving facility,
enclosed bus stop, train station, outdoor swimming pool,
public stair-cases, governmental offices in entirety, partial
outdoors of banquet halls, places of religious worship
including partial outdoors, youth center, nursing homesa.
2014 Smoking in sports stadiums restricted to designated areas,
of no more than a third of entire sitting area.
a = excluding designated smoking areas (until 2001)/ separate smoking room (since 2001).
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cupied by non-smokers), restaurants and snack bars, and
most other indoor public places (although still allowing
for the designation of separate, well-ventilated smoking
rooms). Smoking was prohibited in elementary, middle,
and high schools, (with the exception of designated
teacher smoking rooms). A Ministry of Education direct-
ive issued in 2001 forbade smoking in school yards. Reg-
ulations pursuant to the law required “no smoking”
signage.
In 2007, the Restriction on Smoking in Public Places
Act underwent a major revisiona. As manifested in the
act’s revised name –“Prevention of Smoking in Public
Places and Exposure to Second-Hand Smoke Act 1983”(henceforth Prevention of Smoking Act) – the legisla-
tion’s objective shifted from restriction to prevention.
For that purpose, more rigorous enforcement tools were
legislated. Responsibility for the implementation of the
smoking ban was placed on the shoulders of property
owners, as well as anyone else with jurisdiction over that
place: the owner, a tenant or the authorized official in a
corporation. Fines were increased for those who smoked
in public places, and the owners became liable for rela-
tively large fines (5,000 NIS). Ashtrays were banned in
public places.
Smoking was also prohibited in bars and clubs, except
for separate smoking rooms which were required to oc-
cupy less than 25% of the total area. All existing smoking
Table 3 Regulation of Advertising and Marketing of Tobacco in Israel 1983-2014





and marketing of for-smoking
tobacco products act
1983 Banned advertisement via radio and television,
in or on public transport, in public movie
screenings, and in all printed material primarily
intended for the consumption of minors;
Restriction on Indirect Advertising, a limit placed
on the number of ads allowed for each product
per newspaper, and a ban on the use of human
and animal figures as well as on the praising of
smoking of itself in tobacco ads.
Ministry of
Health
Mandatory health warning added to all tobacco
Product’s packaging.
1995 Mandatory health warning added to all tobacco
adds
Parliament
2001 Extension of the list of forbidden advertisement
venues and means + interchangeable package
health warnings allowed
Parliament
Restriction on advertising and
marketing of tobacco products
regulation (wording of warnings)
2002 Interchangeable health warnings set Ministry of
Health
Consumer protection order
regulation (Marking of goods)
2004 Prohibition against the use of signs, marks
or words the likes of “light”,” low tar”, “mild”




Restriction on advertising and
marketing of tobacco products
act (Name of act changed)
2004 Prohibitions extended to all tobacco products
(not excluded to for-smoking products) + a






marketing venues directed at minors)
2006 A complete ban on tobacco product
advertisement aimed at minors.
Ministry of
Commerce
Tobacco act 2006 Gave the MOH power to govern packaging
of imported tobacco products
Ministry of
Finance
2008 A ban set on the selling of for-smoking
products to minors
Parliament
2011 Added ban on placing tobacco vending
machines in the proximity of educational
institutions
Parliament
2014 Added ban on all placement of tobacco
vending machines
Parliament
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services. Additionally, local authorities were required to
appoint non-smoking inspectors.
In 2012, more venues were included in the smoking
ban. The ban was extended to workplaces in their entir-
ety (with the exception of a separate, well-ventilated,
designated smoking room) and to all government build-
ings, with no exception for designated smoking rooms.
Further, for the first time, some outdoor public areas
were included in the ban: railway platforms, covered
outdoor bus stops, outdoor swimming pools, 75% of the
outdoor areas of bars, pubs, cafes, and party venues such
as wedding halls. The area within 10 meters of entrances
to hospitals and healthcare facilities were also designated
as smoke-free. In June 2014, the law was further
amended to allow for smoking only in designated limitedareas in sports stadiums. A proposed amendment,
restricting smoking in parks where children play [22],
passed its first reading in the Knesset on January 8th
2014. The bill was transferred to the Work, Welfare and
Health committee of the Knesset, but has not been dis-
cussed since the first reading. Details can be found in
Table 2.1983 – present: Marketing regulations (MPOWER: warn
about the dangers of tobacco)
The Restriction on Advertising of Tobacco Products for
Smoking Act was enacted in 1983, with the primary aim
of regulating the public’s exposure to tobacco advertising
and secondary aim of providing a warning regarding the
dangers of smoking.
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vertising power, the Act, renamed the Restriction on
Advertising and Marketing of Tobacco Products (RAMTP),
as amended over the years, also endeavored to promote the
dissemination of anti-smoking information by means of
tobacco health warnings. Tobacco companies were
required to place health warnings on the package of every
tobacco product and on all tobacco advertisements. While
in 1983, only one very small fixed warning text was set by
the actb. Today, the law requires the use of 12 rotating
warnings covering 32% of each major side of tobacco
packages, in Hebrew on one side and in Arabic on the
other, as well as the inclusion, in advertisements, of one of
13 rotating warnings, taking up 5% of the area of the ad
[23]. cEfforts through the years to obligate tobacco
companies to divulge the contents of their products – by
type and amount of each compound – have been un-
productive. (See for example [24]) Similarly, attempts to
expand the public’s exposure to health-promoting infor-
mation, by requiring tobacco products’ packaging to carry
details regarding hazardous components, have not been
successful (See for example [25]).
1983-present: Marketing restrictions (MPOWER: enforce
bans on tobacco advertising, promotion and sponsorship)
Advertising
The primary intent of the Restriction on Advertising of
Tobacco Products Act (RAMPT) was to limit tobacco
advertising. The original prohibitions were related to
combustible tobacco products. The act was extended in
2004 to encompass all tobacco products.
As detailed in Table 3, the RAMTP initially forbade all
tobacco advertising via radio and television, in or on
public transport, in public movie screenings, and in all
printed material primarily intended for minors.
Other restrictions included limits on the number of
ads permitted for each product per newspaper, a ban on
the use of models under the age of 40 in tobacco ads,
which was later extended to the use of all human and
animal figures, and a ban on praise of smoking in to-
bacco ads. The law was later extended to include a ban
on indirect advertising of tobacco products, although
sponsorship of cultural and social events was excluded
from the term “indirect advertisement”, and so allowed,
as long as the event was not child- or youth-designated.
In 2004, the consumer protection order was amended
to prohibit the suggestion of harm-reduced products.
The order specifically banned the use of the terms
low- tar, ultra-light, light, and mild, as well as branding,
graphic description or marking, suggesting the product
was less harmful than others. In 2006 the consumer
protection regulations were amended to completely ban
any advertisement aimed at minors, regardless of mode
of advertising.Penalty for any breach of the act’s provisions was im-
posed on both the company that initiated the campaign
and the advertising body.
Marketing
The marketing of tobacco products to minors has been
forbidden since 2004 through an amendment to the
RAMTPd. Vendors may require customers to present
proof of age, and signage is obligatory. Penalties include
high fines and business license revocation.
In 2001, the RAMTP was amended to authorize the
MoH to forbid placement of tobacco vending machines
in specified areas. This was further amended in 2011 to
ban all vending machines. In the interim period, until
entry of the ban into effect, regulations prohibited the
placement of tobacco-vending machines within 1 kilo-
meter of educational institutions. The ban on vending
machines was challenged and later affirmed by the Is-
raeli High court of Justice [26]. It went into effect in
January 2014. Details can be found in Table 3.
2000 - present: Reports of the health minister to the
Knesset on tobacco (MPOWER: monitor tobacco use and
prevention policies)
In the year 2000, the Israeli parliament passed the
Mandatory Reporting on Health Damages Caused by To-
bacco Smoke Act. The Act required the annual reporting
on prevalence of smoking, MoH tobacco control actions
(legislation, media and educational campaigns), unsuccess-
ful or incomplete legislative attempts (with explanations
for failures); details regarding enforcement of smoke-free
areas; and up-to-date scientific information regarding
smoking health-hazards.
In 2007 the Prevention of Smoking Act was amended
to require local authorities to report enforcement efforts
of the ban on smoking in public places. These reports
were then incorporated into the MoH’s annual report.
The first report came out for the 2001–2002 year. Re-
ports have been published annually since that time.
2010 – present: Governmental subsidization of smoking
cessation technologies (MPOWER: offer help to quit
tobacco use)
Every year, from 2007 until the present, attempts have
been made to add smoking cessation technologies to the
National Basket of Health Services. The basket provides
subsidized medications to all Israeli residents through
the HMOs. The first success was achieved at the end of
2009. At that point, smoking cessation workshops be-
came available without charge. Two smoking-cessation
medications, one under patent (Champix), and one not
under patent (Zyban) were included in the basket, with
heavy subsidies, provisional on attendance at smoking-
cessation workshops.
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Nicotine Replacement Therapy (NRT) was added to the
basket as a second-line tobacco cessation medication.
Smokers attending cessation workshops, and for whom
Champix or Zyban are contraindicated, are entitled to dis-
count. Attempts to allow individuals to obtain Champix
or Zyban with individual or phone counseling instead of
group counseling, and to extend the subsidized period for
tobacco control medications, have been unsuccessful.
A chronological look at tobacco use, exposure, and policy
Figure 1 shows policy initiatives in the context of to-
bacco use over time. Annual data on smoking prevalence
among adult Jewish men and women are presented from
1980. Data on smoking prevalence for Arab men and
women were not regularly collected prior to 1996, and
are shown from that year on.
Changes in tobacco taxation are shown from 2002, com-
paring the percentage of taxation on the price of a pack of
20 cigarettese. Other major policy changes, including
smoke-free regulations, marketing regulations, and the
addition of cessation services to the National Basket of
Health Services are also presented in chronological order.
As seen from the graph, Israel has experienced a major
decrease in the prevalence of smoking in all population
subgroups over the last decades, while simultaneously
going through an increase in taxation as well as in the
general scope of regulatory intervention. A surge in to-
bacco control policy activities can especially be detected
since 2000.
Israel’s National Tobacco Control Plan (NTCP)
Israel’s National Tobacco Control Plan (NTCP), an inte-
grated plan, was built in several distinct phases. The
phases are pictured in Figure 2 and discussed below.
Phase 1: the Gillon Commission
The first attempt to coordinate actions regarding smok-
ing occurred in 1998, as the inadvertent consequence of
a different process. At the time, though the harms of ac-
tive smoking were already well known and basic tobaccoFigure 2 Development of Israeli National Tobacco Control Plan.control legislation had been enacted, the MoH had not
yet begun to systematically address tobacco use or ex-
posure [27]. The Israel Physician’s Association petitioned
Israel’s Supreme Court regarding the MoH’s perceived
inactivity regarding smoking, and to force it/the govern-
ment to regulate nicotine as a controlled substance
under the Dangerous Drugs Ordinance. The MoH’s re-
sponse was that the Dangerous Drugs Ordinance was
not appropriate for regulating nicotine, and that a coor-
dinated strategy to deal with tobacco use was needed in-
stead. The Commission, headed by retired Judge Gillon,
was appointed by the MoH and charged with making
recommendations to decrease smoking and the harm
caused thereby [28].
Topics discussed included the health and economic
damage from smoking, the addictiveness of nicotine, and
the dangers of exposing the public to secondhand
smoke. The committee held extensive public hearings.
The deadline for submitting a final report was extended
seven times, but the report was not submitted.Phase 2: Signing and ratifying the WHO’s Framework
Convention for Tobacco Control (FCTC)
In 2003, the Ministry of Health and the Foreign Ministry,
jointly initiated the signing of the WHO’s Framework
Convention for Tobacco Control (FCTC). The FCTC, the
world’s first health treaty negotiated under the WHO, was
created as a response to the global tobacco epidemic, and
sought to reduce both demand for, and supply of, tobacco
products [29]. This treaty was ratified by Israel in 2005,
formally committing the government of Israel to imple-
ment the FCTC provisions. These provisions included an
overriding governmental commitment to decrease tobacco
use and exposure, through regulation of demand for and
supply of tobacco products.Phase 3: Healthy Israel 2020
As with Phase 1, writing a strategy for a National To-
bacco Control Plan in Phase 3 came as a byproduct of a
different agenda.
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WHO, and, as such, has various obligations, including
the creation of health targets. In 1989, Israel produced
its first set of health targets for the year 2000, in line
with the WHO Health for All policy [30]. In 2004, MoH
officials decided to update the targets. The initiative,
dubbed “Healthy Israel 2020,” [“HI2020”] was built with
inspiration from WHO Europe’s Health For All [31] and
the US Healthy People 2010 [32]. In addition to creating
a set of health targets, the endeavor expanded to identify
evidence-based methods for the achievement of the tar-
gets and prioritization of strategies [33]. Tobacco was
dealt with in a Subcommittee of the Health Behaviors
Committee. The Tobacco Control Subcommittee defined
its primary goals as the reduction of tobacco use and ex-
posure in the population. Eight key elements were rec-
ommended as the basis of a National Tobacco Control
Plan: creation of a central committee to coordinate ef-
forts, taxation, legislation, enforcement, monitoring and
research, community intervention, communication, and
helping smokers quit [34]. However, HI2020 was not
mandated to implement any particular strategies or
programs.
Phase 4: National plan for reduction of smoking and its harm
In 2009, following the formation of a new government
in Israel, both the political and professional leadership of
the MoH changed. One of the first things which the
MoH's new Director General did was to appoint a 5-
member Public Committee to write a National Tobacco
Control Plan (NTCP), which was entitled the National
Plan for Reduction of Smoking and Its Harm. The idea
was to create an operational plan based on the work
done in the context of HI2020. The emphasis from the
outset was on legislation, so as not to be dependent on
the willingness of the government to fund activities.
Within six months, the preparation of the plan was
complete. It included many elements from the 2020 plan,
in particular, the establishment of a central body for to-
bacco control (now defined by the Public Committee as
being within the MoH), creation of a comprehensive to-
bacco control policy with measurable goals, taxation, help-
ing smokers to quit, protecting non-smokers from
tobacco smoke exposure, use of media, and preventing
youth initiation. Additional areas, which were adopted by
the Public Committee but not covered by the 2020 plan,
included the appointment of a committee to deal with en-
vironmental pollution from cigarette butts, and the devel-
opment of a targeted plan for reducing the high smoking
prevalence among Arab males.
As broad support of the national plan was considered
essential for passage of laws which would likely be op-
posed by an active and vocal tobacco lobby, the plan was
first presented as a whole to the Israeli Cabinet (“thegovernment”) for approval; thereafter, the proposed le-
gislation was submitted, as required, to the government
committee on legislation, after having already been ap-
proved in principle by the government.
Phase 5: Approval in Knesset of the National Tobacco
Control Plan and subsequent regulatory actions
The plan was approved by the Cabinet in May, 2011
[27]. For the first time in Israel, tobacco control made
front-page news, and passage of the plan was accompan-
ied by a lively public discussion in the media.
To date, several bills have been submitted to the Knes-
set in the wake of the NTCP. The first, submitted in
May, 2012, concerned extensions to the law on smoking
in public places. Most of these recommendations be-
came law in July 2012.
In the summer of 2012, the MoH submited a bill
which (amongst other proposed measures) would deem
all advertising of cigarette products illegal, with limited
exceptions to be determined. Larger warnings would be
required on approved advertisments, and the MoH
would be permitted to require graphic warnings on
cigarette packages [35]. The bill was approved by the
government and passed its first reading in a session of
the 18th Knesset. After the 2013 elections, the bill pro-
ceeded to the new 19th Knesset’s Economics Committee
for further deliberation and refinment, where it encoun-
tered major opposition. This opposition, led by tobacco
lobbyists, and aided by the personal and political shift in
the committee’s composition, led to extensive significant
revisions in the original bill’s wording. In March 2014, in
light of those changes, which the MoH viewed as contra-
dicting the original logic and aim of the bill, the bill was
withdrawn by the MoH. To date, no further progress
has been made.
There has also been some action on the issue of elec-
tronic cigarettes. The MoH convened a committee to in-
vestigate the issue, which, in 2012, called for a five year
moratorium, banning production, import and sales of e-
cigs. The goal was to allow the scientific evidence on the
harms and benefits of e-cigs to be accumulate before
allowing entry of the product into the Israeli marketplace.
The committee’s recommendation, as well as the MoH’s
position, defining e-cigs as “medical products” – to be reg-
ulated through the Pharmacists Regulations [36], were
presented to e-cigarettes manufacturers in May 2013,
resulting in their prompt appeal to the Israeli High Court
of Justice (HCoJ), requesting an injunction order against
the MoH intention to ban production, import and sales of
e-cigs through the Pharmacists Regulationsf.
In December 2014 the Israeli High Court of Justice
(HCoJ) rulled that the MoH is forbidden to restrict the
production, import and marketing of e-cigs for recre-
ational use through existing regulations, and may only
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approval in the Knesset [37]. By contrast, marketing of
e-cigs for medicinal use (e.g., smoking cessation or other
medicinal purposes) requires authorization by the
Pharmaceutical Division of the MoH, and is currently il-
legal, as such authorization has not been granted.
Anticipating this result, the MoH drafted and distrib-
uted such a bill for comments in September 2014, prior
to the HCoJ’s ruling, proposing to ban the production,
import, marketing and advertising of e-cigs and its re-
lated products, as well as applying the ban on smoking
in public places to e-cigs [38]. The proposed bill has not
yet been submitted to the Knesset.
Discussion
Although impressive in its scope, the Israeli tobacco
regulatory scheme until 2011 was not driven by a unify-
ing or comprehensive strategy. Different governmental
ministries regulated various aspects of use, manufactur-
ing and import of tobacco. Restrictions on smoking in
public places, as well as advertising and marketing re-
strictions, were under the regulatory authority of the
MoH; tobacco taxation was under the jurisdiction of the
Finance Ministry, and possible subsidization of tobacco
manufacturing was under the jurisdiction of the Ministry
of Industry and Commerce (now, the Ministry of Econ-
omy). There was often collaboration on main issues be-
tween Ministries, with advice being sought from the
Ministry of Health. Yet, at times, the lack of a single au-
thority led to inconsistent governmental actions and
messagesg.
This lack of central control – though not the authority
of the various Ministries - changed with the creation
and passage of the National Tobacco Control Plan in
2011. The passage of that plan brought two major
changes. First, there is now a central coordinating to-
bacco control body in the MoH. That body, with three
allotted full-time positions, coordinates tobacco control
efforts throughout the government, informally coordi-
nates some of the efforts in the public (non-profit), vol-
untary, and academic sectors, and is awaiting final
approval to enforce tobacco control laws. Second, the
coordinating body has a clear plan which it is systemat-
ically attempting to promote. As planned, taxation is be-
ing incrementally increased, for cigarettes and other
types of tobacco products, and regulations extending
smoke-free public places have received legislative ap-
proval. The submitted bill to limit advertising stalled and
was unfortunately rescinded. The MoH has also initiated
approaches not included in the NTCP, such as recom-
mendations on policy regarding electronic cigarettes.
Sporadic tobacco policy initiatives from outside the Min-
istry continue, most recently for fostering smoke-free
public parks where children playh.Although tobacco control activities have achieved signifi-
cant improvement in smoking prevalence over the years,
achievements elsewhere show that the potential exists for
even greater progress. For example, smoking prevalence in
2013 in New York, Massachusetts, and Florida was about a
sixth of the population, and in California was 12.5%
[39]. All four of these states had exemplary tobacco
intervention programs, and all have smoking rates
which are lower than the national average [40,41].
Though Israel was once a leader in tobacco control,
many countries currently have stronger tobacco control
policies than does Israel. For example, though bans on
advertising combined with point of sale restrictions have
been shown to substantially decrease youth uptake,
Israel lags behind on marketing, sponsorship, and pro-
motion restrictions. By contrast, bans on local news-
paper and magazine advertising exist in 45 of the 53
countries which form a part of the World Health Orga-
nization’s European Region; Israel is one of the few with-
out such bans. Most (34/53) of these countries also
prohibit internet advertising, though Israel does not.
Sponsorship is also prohibited in a majority of these
countries (29/53), though Israel allows it [42].
Further, some countries have created the goal of being
tobacco free by a certain year; these include New Zealand
(2025), Finland (2040), and Scotland (2034) [43].
Researchers have quantified effects of policy interven-
tions on tobacco-related mortality and smoking-
attributable deaths [44,45]. Jha emphasized the import-
ance of taxation [45], while Levy, in an analysis of 41
countries, found that the largest number of smoking-
attributable deaths was averted by taxation (47%),
followed by smoke-free air laws (34%), warnings about
harm (9%), cessation treatments (5%), and bans on mar-
keting (4%) [44].
We propose recommendations to improve tobacco
control policy in Israel, beyond the policies which have
already been implemented (such as creation of a coord-
inating body for tobacco control and subsidization of to-
bacco cessation technologies) or which are being dealt
with (such as increases in taxation).
Recommendations
The recommendations are described below and sum-
marized in Table 4. For each recommendation, we note
if it was included in the National Tobacco Control
Plan (NTCP), Healthy Israel 2020 (HI2020), the FCTC
(with Article), or MPOWER (with appropriate letter
underlined).
Guarantee funding for tobacco control (NTCP, FCTC
article 5)
Though the NTCP was written with the hope of obtain-
ing substantial funding, in practice this did not occur.
Table 4 Recommendations for additional tobacco control policy measures in Israel
Recommendation Supported by
Guarantee funding for tobacco control NTCP, FCTC Article 5
Place strong curbs on tobacco industry advertising, marketing, and promotion NTCP, HI2020, FCTC Article 13, MPOWER
Educate the Israeli public about the dangers of smoking and exposure to tobacco
smoke
NCTP, HI2020, MPOWER
Enforce tobacco control laws NTCP, HI 2020, FCTC Articles 7 and 8, MPOWER
Protect children from tobacco smoke exposure HI2020
Develop and implement a wise policy for e-cigarettes, other harm-reducing products,
and alternative forms of tobacco
Monitor the implementation and effectiveness of the NTCP and other tobacco control
policies, and perform core tobacco control research
HI2020, FCTC (Article 5), MPOWER
Periodically update the NTCP, and include an Endgame strategy FCTC (Article 5)
NTCP: Israel National Tobacco Control Plan.
HI2020: Healthy Israel 2020.
FCTC: World Health Organization’s Framework Convention on Tobacco Control.
MPOWER: World Health Organization’s suggested measures to assist in country-level implementation of effective interventions to reduce demand for tobacco.
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trated on requirements and prohibitions, not accompan-
ied by sufficient educational or enforcement measures
(which require greater funding). This lack could be recti-
fied by legislating that a small percentage of the billions
of NIS (6.1 billion NIS in 2013) procured annually
through tobacco taxation be funneled to tobacco con-
trol. To date, the Treasury has refused to consider this,
as part of its economy-wide policy of opposing ear-
marked taxes. Another possibility would be to institute a
“user fee” on the tobacco industry, such as was done by
the U.S. Congress to fund the F.D.A Center for Tobacco
Products.
Place strong curbs on tobacco industry advertising,
marketing, and promotion (NTCP, HI2020, FCTC article 13,
MPOWER)
The limited extent of the advertising restrictions, and
the existence of tobacco promotion and sponsorship,
represent a severe limitation of current Israeli tobacco
control policy. Tobacco companies have increased their
funding for marketing, advertising, and promotion sub-
stantially in recent years, from 37.6 million NIS in 2007
to 61.3 million NIS in 2012 [4], p72-.73). Internet adver-
tising is restricted in the same manner as other advertis-
ing, with restrictions on advertisements aimed at youth,
but the restrictions are not enforced. Newspaper adver-
tising remains legal, and the ongoing promotion and
sponsorship of tobacco products severely limit the ef-
fectiveness of tobacco control measures.
Educate the Israeli public about the dangers of smoking
and exposure to tobacco smoke (NCTP, HI2020, MPOWER)
Significant educational effort requires extensive invest-
ment on part of the government, in terms of both
money and expertise. Educational initiatives as well asresources may also originate in the voluntary sector, in-
cluding the cancer associations and HMOs. In Israel, the
Israel Cancer Association has taken an active role in
educational efforts.
Data from European countries show that educational
campaigns, which clearly explained that smoke-free le-
gislation is intended to protect people against harm from
exposure to secondhand smoke, can influence smokers’
support for tobacco control laws [46]. The fact that Is-
rael’s smoke-free legislation is not well adhered to
[47-49] may be partly attributable to the lack of media
campaigns and other educational efforts accompanying
the legislation. This lack is especially critical in view of
the fact that over 60% of non-smoking Israelis are regu-
larly exposed to tobacco smoke [15]. Particularly among
the poorly educated, who have higher smoking rates
[50], and less awareness of the dangers of smoking [51],
knowledge imparted by educational efforts and media
campaigns may increase support and cooperation with
tobacco control policies.
Enforce tobacco control laws (NTCP, HI 2020, FCTC
articles 7 and 8, MPOWER)
In the absence of education regarding harm related to sec-
ond hand smoke, and incomplete public compliance to
no-smoking requirements, the need for effective enforce-
ment is clear. Yet this also has not been given sufficient at-
tention. Local authorities were found to implement
incoherent and limited enforcement activity, while the
municipal inspectors were found to be uncomfortable
assigning high cost penalties [48]. Supporting these find-
ings is the low number of fines given [4], implying a low
level of law enforcement in areas which are legislated to
be smoke-free but documented to have high levels of
smokiness [47]. Indeed, the smoking ban’s enforcement by
Israeli authorities has been so sparse that it prompted the
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the ban, through private damage claimsi.
Full realization of the Israeli smoking ban requires
additional training of the ban’s enforcers, in order to in-
crease the knowledge of inspectors regarding the haz-
ards of second hand smoke, and to convince them that
they are saving lives when they impose a fine [48]. In
addition, intervention at the level of the Municipalities
and monitoring inspector behavior could be helpful.
In 2013, a Smoking Prevention Division was estab-
lished inside the MoH’s department for enforcement and
supervision. Amongst other activities, the division is
planning to train and educate local smoke-free inspec-
tors on the importance of the proper application of their
authority [4]. [pp. 62–63] However, the legislation to
allow MoH employees themselves to enforce smoke-free
laws has not yet been finalized.
Protect children from tobacco smoke exposure (HI2020)
Children are especially vulnerable to the hazardous ef-
fects of tobacco smoke exposure [1] and need special
protection, whether in public or private spheres. Current
laws against smoking in schools are not enforced, and
teacher smoking rooms remain legal. There are no laws
in Israel preventing smoking in cars carrying children, in
spite of the high levels of tobacco smoke exposure in ve-
hicles where smoking takes place [52,53]. Such laws have
been recommended by major organizations, including
the U.S. Environmental Protection Agency [54], the
American Lung Organization, and the U.S. Institute of
Medicine [55], and have been passed in places such as
Ontario, Canada and Oregon, U.S. [56] Policies which
protect children at home, in cars, in school, and in pub-
lic places should be carefully considered, in light of the
potential to protect future generations and the complex-
ity of regulating the private sphere.
Develop and implement a wise policy for e-cigarettes,
other harm-reduction products, and alternative forms of
tobacco
There are many alternative and emerging forms of to-
bacco and smoking around the world. Because the mag-
nitude and scale of risk differs with different forms of
use, some professionals argue that harm reduced prod-
ucts should be encouraged. Others maintain that aboli-
tion of tobacco is the most practical path to improved
population health [57]. Snus, widely used in Sweden but
banned from other European countries, is credited with
very low levels of tobacco-caused disease in Sweden
[58]. (p. 76, p.198) In recent years, electronic cigarettes
(e-cigarettes) have dominated the harm reduction debate.
The tobacco control and public health communities
abroad and in Israel are divided as to whether e-cigarettes
represent a less dangerous alternative to smoking, withthe potential to save lives and improve health, or whether
it will re-normalize and re-glamorize smoking, thus acting
as a gateway to cigarette smoking, and ending decades of
progress in tobacco control [59]. Though a complete pic-
ture of the short and long-term risks from e-cigarettes, in-
cluding their potential effect on population-level smoking
of combustible products, is unknown, the present data in-
dicate that e-cigarettes are far less deadly than traditional
combusted cigarettes [60].
In Israel, a wise policy for recreational use of electronic
cigarettes would include: restrictions on advertising, mar-
keting and promotion (including prohibition of e-
cigarettes sales to minors and a complete ban on internet
advertising); quality assurance; appropriate warnings (par-
ticularly so as to prevent deaths from ingestion of e-liquid,
and clearly inform the public of known and unknown
risks); and disclosure of ingredients. Policy should be reex-
amined as new information becomes available.
The current policy of an unrestricted electronic cigarette
market (excluding for medicinal purposes) ensures that
market forces, with capital gains as the primary endpoint,
dominate the landscape. This will continue until the gov-
ernment takes strong policy action.
Monitor the implementation and effectiveness of the
NTCP and other tobacco control policies, and perform
core tobacco control research (HI2020, FCTC (Article 5),
MPOWER)
At present, there is no formal plan for scientifically evalu-
ating the effectiveness of the NTCP or other tobacco con-
trol policies in Israel, nor are there dedicated funds for
this or for core tobacco control research. A small amount
of research has been conducted on assessment of the laws
enacted, primarily by academic researchers [47-49]. The
MoH does internally review progress on implementation
of the plan, but this information is not available to the
public. The annual report of the Health Minister is sub-
mitted to the Knesset and discussed there, but does not
specifically address evaluation of the NTCP. Cigarette
smoking behavior is currently monitored by the MoH
with its Knowledge, Attitudes, and Behavior (KAP) survey.
A stronger research plan would include monitoring of: all
elements of the NTCP; use of tobacco in any form and
smoking products, including electronic cigarettes; public
opinion and social norms regarding tobacco and tobacco
control policies; objective measurement of tobacco smoke
exposure among Israelis; tobacco industry activities, and
content of tobacco and smoking products. The Population
Assessment of Tobacco and Health (PATH), which is be-
ing conducted in the US [61], is an important example of
core tobacco control research. This type of research would
carefully monitor changes in use of various tobacco and
smoking products by the Israeli public, and identify areas
for intervention.
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include an endgame strategy
The NTCP, while based on the important sources of to-
bacco control both within and without Israel, is a docu-
ment based on information and challenges relevant at
the time it was written. New issues – such as electronic
cigarettes – have emerged since then; new information
is available on the implementation and failure of some
of the NTCP’s components; and innovative approaches
to tobacco control, such as plain packaging in Australia,
are being discussed and implemented elsewhere. “End-
game” scenarios, in which cigarette smoking and tobacco
use is drastically reduced into a marginal activity by a
small percentage of the population, largely through in-
novative regulatory actions, have received a fair amount
of attention [62]. Some researchers have even called for
abolition of smoking [57] to battle the enormous toll of
tobacco on society. These issues need addressing now,
and others will arise in the future. We recommend that
a periodic review of novel approaches and issues be con-
ducted, in light of tobacco control progress in Israel and
elsewhere.
Conclusions
Israel has an impressive record of tobacco control policy,
which includes steadily increasing taxation, comprehen-
sive smoke-free laws, heavily subsidized cessation services,
partial advertising restrictions, and a recently-adopted Na-
tional Tobacco Control Program. Though once fragmen-
ted and sporadic, tobacco policy today in Israel is
coordinated within the MoH, and has a comprehensive
plan which it is promoting. Intermittent initiatives unre-
lated to the NTCP continue. That said, the death toll in
2014 from smoking is expected to exceed combined mor-
tality from vehicle accidents, suicides, murder, obesity,
lack of physical activity, and motor vehicle emissions;
nearly a fifth of the population smokes, with smoking
among Arab males close to 40%; existing smoke-free laws
are poorly enforced, most of the nonsmoking public
suffers from regular tobacco smoke exposure, internet
advertising is nearly unrestricted, e-cigarettes for non-
medical use, both with and without nicotine, are un-
regulated, and the tobacco industry invests enormous
sums in advertising, marketing, and promotion in
Israel. In order to prevent hundreds of thousands of fu-
ture premature, preventable deaths, is time to begin to
discuss Endgame scenarios, and to put the possiblity of
abolition on the table.
Endnotes
aThe amendment followed Israel’s ratification of the
Framework Convention on Tobacco Control, and was
likely a reaction to Israel’s Supreme Court’s judicial criti-
cism, in Civil Appeal Permit 9616/05 Shemesh v.Fokacheta (5/7/06), on the lack of enforcement of the
no-smoking ban, as designed up to that time.
bThe warning stated that “The MOH states that smok-
ing is harmful to people’s health”.
cThese include such warnings as “Medical research
shows that smoking causes impotency” and “When you
smoke you harm those close to you”.
dUnder the Israeli law a “minor” is a person under the
age of 18.
eBased on the calculated pack price for Marlboro and
Time cigarettes.
fThe e-cigs companies’ main claim was that e-cigs do
not fall under the term “medical product”, thus falling
out of the MoH’s authority to ban production, import
and sales of medical products, through the Pharmacists
Regulations.
gA good example of this can be found in the Ministry
of Industry and Commerce’s (MoCI) decision to
subsidize the operation of a planned tobacco factory
near the city of Safed. The decision was based on socio-
economic considerations which are made at the discre-
tion of the MoCI: the goal of encouraging the develop-
ment of work places in the periphery of Israel is among
these. Nevertheless, the subsidizing decision stood in
direct contrast to the anti-smoking message promoted
by the MOH. The subsidizing decision was challenged
in the Israeli Supreme Court by the Israeli Cancer As-
sociation. Although sympathetic to the petition, and
critical of its consequent mixed message, the court re-
fused to intervene in the decision, claiming that MoCI
was authorized to make it, and autonomous in doing
so. High Court of Justice’s case 194/88 The Israeli
Cancer Association v. The Director of the Invest-
ment Center (7/9/1988).
hThe formal initiator of that bill was the Israel Physi-
cian’s Association; the individuals involved were members
of the Healthy Israel Tobacco Control Sub-Committee.
iIn 2006 the Supreme Court ruled in favor of a plaintif,
Irit Shemesh, who claimed to be harmed, along with her
husband, by second hand smoke, while in a restaurant
called Focacheta that allowed for smoking on its prem-
ises. Although offences under the Prevention of Smoking
in Public Places and Exposure to Second-Hand Smoke
Act of 1983 are criminal violations, and the law does not
explicitly recognize personal compensable harm due to
second-hand-smoke, the Supreme Court recognized the
ban’s lack of enforcement as a basis for a personal harm
claim, and stated that:
“The heaviness and slowness of the law enforcement
authorities’ actions justify opening the door for
‘civil enforcing’, so that a concerned citizen who
wishes to maintain his health as well as the public’s
health would also be able to contribute to the
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v. Fokacheta (5/7/06) Art. 4] The effectiveness of the
court’s ruling as a deterrence tool has been limited,
though, since not many citizens, injured by second-
hand-smoke, are willing to take it upon themselves to
go to court and endure a lengthy legal process, for the
sake of being awarded the sum of approximately 1,500
NIS (about 429$) – the sum awarded to Mr. Shemesh”.
Nonetheless, this problem is expected to be mitigated,
as the result of the Supreme Court’s 2013 ruling against
the Bella Shlomkin’s club. A class action was brought
against the club, based on the Shemesh v. Focacheta
ruling, for harm caused to its patrons, due to the club’s
failure to implement the smoking ban during a month in
2008. While the district court ordered the club to pay
the Israeli Cancer Association 90,000 NIS for failing
to ensure no smoking on the premises (Class Action
(central district) 4398-09-08 Litvin v. Bella Shlomkins
(Issued 26.1.2009)) the Supreme Court, sitting as the
Court of Civil Appeals, decided to increase the club’s
compensation payment to 1.16 million NIS (about
331,700$). This sum calculates a compensation of 1,000
NIS per patron (estimating 1,160 patrons per month).
(Civil Appeal 2150/11 Litvin v. Bella Shlomkins (Issued
6.6.2013).
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